Skip to content

A Randomised Controlle Study of Vaginal Bromocriptine and Oral Carbegoline in treating Hyperprolacrinemia among women Attending Infertility Clinic in Abuth

A Randomised Controlle Study of Vaginal Bromocriptine and Oral Carbegoline in treating Hyperprolacrinemia among women Attending Infertility Clinic in Abuth

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202105785593643
Enrollment
60
Registered
2021-05-17
Start date
2020-11-01
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fertility-female

Interventions

Sponsors

Irshad Asma
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Infertile women with hyperprolactinemia confirmed by measuring fasting serum prolactin levels. 2. Women who give informed consent to participate in the study. 3. Women who are motivated to comply with study requirements including clinic visits, repeated blood sampling, vaginal drug administration and timely use of medication.

Exclusion criteria

Exclusion criteria: 1. Women with space occupying lesions or other complications requiring urgent intervention. 2. Women with active genital tract infections or cancers. 3. Renal or hepatic insufficiency. 4. Women who were already on treatment at the time of the study. 5. Women who were unable to provide informed consent. 6. Women with allergies to any component of the drugs.

Design outcomes

Primary

MeasureTime frame
1.Percentage fall in serum prolactin levels during treatment in both arms of the study. 2.Proportion of women who experience side-effects in both arms of the study.

Secondary

MeasureTime frame
1. Proportion of women in both arms who achieve symptom relief following treatment.

Countries

Nigeria

Contacts

Public ContactAliyu Sokomba

Senior Resident Ahmadu Bello University Teaching Hospital

drsokomba@gmail.com+2348035935832

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026